Insider Transactions in Q2 2025 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$130,000
$13.86 P/Share
|
|
Jun 25
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
Jun 24
2025
|
Mario Alberto Accardi President, Orexin Program |
SELL
Open market or private sale
|
Direct |
15,000
-6.48%
|
$210,000
$14.0 P/Share
|
|
Jun 24
2025
|
Mario Alberto Accardi President, Orexin Program |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.09%
|
$45,000
$3.85 P/Share
|
|
Jun 24
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
12,000
-10.22%
|
$168,000
$14.02 P/Share
|
|
Jun 24
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+9.27%
|
$60,000
$5.84 P/Share
|
|
Jun 20
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$660,000
$12.63 P/Share
|
|
Jun 20
2025
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+16.62%
|
$165,000
$3.85 P/Share
|
|
May 27
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-7.56%
|
$120,000
$12.82 P/Share
|
|
May 27
2025
|
Gregory M Weinhoff Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.03%
|
$30,000
$3.85 P/Share
|
|
May 20
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
55,000
-19.93%
|
$660,000
$12.71 P/Share
|
|
May 20
2025
|
Saurabh Saha Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+16.62%
|
$165,000
$3.85 P/Share
|
|
May 16
2025
|
Arjun Goyal Director |
BUY
Open market or private purchase
|
Indirect |
417,646
+47.45%
|
$5,011,752
$12.73 P/Share
|
|
May 15
2025
|
Arjun Goyal Director |
BUY
Open market or private purchase
|
Indirect |
44,939
+50.0%
|
$539,268
$12.24 P/Share
|
|
May 01
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
311
-0.29%
|
$4,354
$14.0 P/Share
|
|
May 01
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
311
+0.29%
|
$1,555
$5.84 P/Share
|
|
Apr 28
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
2,080
-1.94%
|
$29,120
$14.01 P/Share
|
|
Apr 28
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,080
+1.9%
|
$10,400
$5.84 P/Share
|
|
Apr 25
2025
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
3,609
-3.31%
|
$50,526
$14.0 P/Share
|
|
Apr 25
2025
|
Iqbal J Hussain General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,609
+3.21%
|
$18,045
$5.84 P/Share
|
|
Apr 25
2025
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,742
-8.76%
|
$152,646
$13.61 P/Share
|
|
Apr 22
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,344
-15.44%
|
$484,128
$12.43 P/Share
|
|
Apr 21
2025
|
Saurabh Saha Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,656
-5.31%
|
$175,872
$12.29 P/Share
|